Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1986 Aug 15;135(4):297–301.

Growth hormone therapy in Canada: end of one era and beginning of another.

H J Dean, H G Friesen
PMCID: PMC1491444  PMID: 3089574

Abstract

This paper reviews the difficulties in diagnosing a true deficiency of growth hormone (GH), the long-term results of therapy, the Canadian experience in treating GH deficiency, including the contributions made by the Medical Research Council's Therapeutic Trial of Human Growth Hormone, and the occurrence of Creutzfeldt-Jakob disease in recipients of GH therapy. It also speculates on potential alternatives to treatment with GH derived from human pituitaries.

Full text

PDF
297

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BECK J. C., MCGARRY E. E., DYRENFURTH I., VENNING E. H. Metabolic effects of human and monkey growth hormone in man. Science. 1957 May 3;125(3253):884–885. doi: 10.1126/science.125.3253.884. [DOI] [PubMed] [Google Scholar]
  2. Brown P., Gajdusek D. C., Gibbs C. J., Jr, Asher D. M. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med. 1985 Sep 19;313(12):728–731. doi: 10.1056/NEJM198509193131205. [DOI] [PubMed] [Google Scholar]
  3. Burns E. C., Tanner J. M., Preece M. A., Cameron N. Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone. Eur J Pediatr. 1981 Oct;137(2):155–164. doi: 10.1007/BF00441309. [DOI] [PubMed] [Google Scholar]
  4. Dean H. J., Kellett J. G., Bala R. M., Guyda H. J., Bhaumick B., Posner B. I., Friesen H. G. The effect of growth hormone treatment on somatomedin levels in growth hormone-deficient children. J Clin Endocrinol Metab. 1982 Dec;55(6):1167–1173. doi: 10.1210/jcem-55-6-1167. [DOI] [PubMed] [Google Scholar]
  5. Dean H. J., McTaggart T. L., Fish D. G., Friesen H. G. The educational, vocational, and marital status of growth hormone-deficient adults treated with growth hormone during childhood. Am J Dis Child. 1985 Nov;139(11):1105–1110. doi: 10.1001/archpedi.1985.02140130043027. [DOI] [PubMed] [Google Scholar]
  6. Frazer T., Gavin J. R., Daughaday W. H., Hillman R. E., Weldon V. V. Growth hormone--dependent growth failure. J Pediatr. 1982 Jul;101(1):12–15. doi: 10.1016/s0022-3476(82)80171-6. [DOI] [PubMed] [Google Scholar]
  7. Gelato M. C., Ross J. L., Malozowski S., Pescovitz O. H., Skerda M., Cassorla F., Loriaux D. L., Merriam G. R. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency. J Clin Endocrinol Metab. 1985 Sep;61(3):444–450. doi: 10.1210/jcem-61-3-444. [DOI] [PubMed] [Google Scholar]
  8. Gertner J. M., Genel M., Gianfredi S. P., Hintz R. L., Rosenfeld R. G., Tamborlane W. V., Wilson D. M. Prospective clinical trial of human growth hormone in short children without growth hormone deficiency. J Pediatr. 1984 Feb;104(2):172–176. doi: 10.1016/s0022-3476(84)80987-7. [DOI] [PubMed] [Google Scholar]
  9. Gibbs C. J., Jr, Gajdusek D. C., Asher D. M., Alpers M. P., Beck E., Daniel P. M., Matthews W. B. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science. 1968 Jul 26;161(3839):388–389. doi: 10.1126/science.161.3839.388. [DOI] [PubMed] [Google Scholar]
  10. Gibbs C. J., Jr, Joy A., Heffner R., Franko M., Miyazaki M., Asher D. M., Parisi J. E., Brown P. W., Gajdusek D. C. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med. 1985 Sep 19;313(12):734–738. doi: 10.1056/NEJM198509193131207. [DOI] [PubMed] [Google Scholar]
  11. Guillemin R., Brazeau P., Böhlen P., Esch F., Ling N., Wehrenberg W. B. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982 Nov 5;218(4572):585–587. doi: 10.1126/science.6812220. [DOI] [PubMed] [Google Scholar]
  12. Guyda H., Friesen H., Bailey J. D., Leboeuf G., Beck J. C. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy. Can Med Assoc J. 1975 Jun 7;112(11):1301–1309. [PMC free article] [PubMed] [Google Scholar]
  13. Huseman C. A. Growth enhancement by dopaminergic therapy in children with intrauterine growth retardation. J Clin Endocrinol Metab. 1985 Sep;61(3):514–519. doi: 10.1210/jcem-61-3-514. [DOI] [PubMed] [Google Scholar]
  14. Joss E., Zuppinger K., Schwarz H. P., Roten H. Final height of patients with pituitary growth failure and changes in growth variables after long term hormonal therapy. Pediatr Res. 1983 Aug;17(8):676–679. doi: 10.1203/00006450-198308000-00015. [DOI] [PubMed] [Google Scholar]
  15. Kaplan S. L., Underwood L. E., August G. P., Bell J. J., Blethen S. L., Blizzard R. M., Brown D. R., Foley T. P., Hintz R. L., Hopwood N. J. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet. 1986 Mar 29;1(8483):697–700. doi: 10.1016/s0140-6736(86)91098-6. [DOI] [PubMed] [Google Scholar]
  16. Miller J. D., Tannenbaum G. S., Colle E., Guyda H. J. Daytime pulsatile growth hormone secretion during childhood and adolescence. J Clin Endocrinol Metab. 1982 Nov;55(5):989–994. doi: 10.1210/jcem-55-5-989. [DOI] [PubMed] [Google Scholar]
  17. Milner R. D., Burns E. C. Investigation of suspected growth hormone deficiency. On behalf of the Health Services Human Growth Hormone Committee. Arch Dis Child. 1982 Dec;57(12):944–947. doi: 10.1136/adc.57.12.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Milner R. D. Which children should have growth hormone therapy? Lancet. 1986 Mar 1;1(8479):483–485. doi: 10.1016/s0140-6736(86)92938-7. [DOI] [PubMed] [Google Scholar]
  19. Pintor C., Cella S. G., Corda R., Locatelli V., Puggioni R., Loche S., Müller E. E. Clonidine accelerates growth in children with impaired growth hormone secretion. Lancet. 1985 Jun 29;1(8444):1482–1485. doi: 10.1016/s0140-6736(85)92256-1. [DOI] [PubMed] [Google Scholar]
  20. Plotnick L. P., Lee P. A., Migeon C. J., Kowarski A. A. Comparison of physiological and pharmacological tests of growth hormone function in children with short stature. J Clin Endocrinol Metab. 1979 May;48(5):811–815. doi: 10.1210/jcem-48-5-811. [DOI] [PubMed] [Google Scholar]
  21. Powell-Jackson J., Weller R. O., Kennedy P., Preece M. A., Whitcombe E. M., Newsom-Davis J. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet. 1985 Aug 3;2(8449):244–246. doi: 10.1016/s0140-6736(85)90292-2. [DOI] [PubMed] [Google Scholar]
  22. Robertson H. D., Branch A. D., Dahlberg J. E. Focusing on the nature of the scrapie agent. Cell. 1985 Apr;40(4):725–727. doi: 10.1016/0092-8674(85)90328-9. [DOI] [PubMed] [Google Scholar]
  23. Rogol A. D., Blizzard R. M., Johanson A. J., Furlanetto R. W., Evans W. S., Rivier J., Vale W. W., Thorner M. O. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature. J Clin Endocrinol Metab. 1984 Oct;59(4):580–586. doi: 10.1210/jcem-59-4-580. [DOI] [PubMed] [Google Scholar]
  24. Rudman D., Kutner M. H., Blackston R. D., Cushman R. A., Bain R. P., Patterson J. H. Children with normal-variant short stature: treatment with human growth hormone for six months. N Engl J Med. 1981 Jul 16;305(3):123–131. doi: 10.1056/NEJM198107163050302. [DOI] [PubMed] [Google Scholar]
  25. Spiliotis B. E., August G. P., Hung W., Sonis W., Mendelson W., Bercu B. B. Growth hormone neurosecretory dysfunction. A treatable cause of short stature. JAMA. 1984 May 4;251(17):2223–2230. [PubMed] [Google Scholar]
  26. Takano K., Hizuka N., Shizume K., Ling N. C. Plasma GH response to hpGRF-44 in normal children of short stature and patients with GH deficiency. Endocrinol Jpn. 1984 Feb;31(1):41–48. doi: 10.1507/endocrj1954.31.41. [DOI] [PubMed] [Google Scholar]
  27. Takano K., Hizuka N., Tanaka I., Shizume K. Effects of hGRF treatment of a patient with hGRF deficiency. Endocrinol Jpn. 1985 Aug;32(4):511–516. doi: 10.1507/endocrj1954.32.511. [DOI] [PubMed] [Google Scholar]
  28. Takano K., Shizume K., Hizuka N., Hibi I., Kato K., Kohno H., Kondo T., Ogawa M., Okada Y., Sudo M. Treatment of idiopathic pituitary dwarfism with methionyl human growth hormone. Endocrinol Jpn. 1983 Aug;30(4):523–527. doi: 10.1507/endocrj1954.30.523. [DOI] [PubMed] [Google Scholar]
  29. Taylor D. M., Dickinson A. G., Fraser H., Robertson P. A., Salacinski P. R., Lowry P. J. Preparation of growth hormone free from contamination with unconventional slow viruses. Lancet. 1985 Aug 3;2(8449):260–262. doi: 10.1016/s0140-6736(85)90302-2. [DOI] [PubMed] [Google Scholar]
  30. Tokuhiro E., Dean H. J., Friesen H. G., Rudman D. Comparative study of serum human growth hormone measurement with NB2 lymphoma cell bioassay, IM-9 receptor modulation assay, and radioimmunoassay in children with disorders of growth. J Clin Endocrinol Metab. 1984 Mar;58(3):549–554. doi: 10.1210/jcem-58-3-549. [DOI] [PubMed] [Google Scholar]
  31. Underwood L. E. Report of the conference on uses and possible abuses of biosynthetic human growth hormone. N Engl J Med. 1984 Aug 30;311(9):606–608. doi: 10.1056/NEJM198408303110925. [DOI] [PubMed] [Google Scholar]
  32. Valenta L. J., Sigel M. B., Lesniak M. A., Elias A. N., Lewis U. J., Friesen H. G., Kershnar A. K. Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers. N Engl J Med. 1985 Jan 24;312(4):214–217. doi: 10.1056/NEJM198501243120405. [DOI] [PubMed] [Google Scholar]
  33. Van Vliet G., Styne D. M., Kaplan S. L., Grumbach M. M. Growth hormone treatment for short stature. N Engl J Med. 1983 Oct 27;309(17):1016–1022. doi: 10.1056/NEJM198310273091703. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES